rs1553333432
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000179.3(MSH6):c.3850_3857dupACGTTCCT(p.Tyr1287ArgfsTer43) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L1286L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000179.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- intellectual developmental disorder with dysmorphic facies and behavioral abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
This sequence change inserts 8 nucleotides in exon 9 of the MSH6 mRNA (c.3850_3857dupACGTTCCT), causing a frameshift at codon 1287. This creates a premature translational stop signal in the penultimate exon of the MSH6 mRNA (p.Tyr1287Argfs*43). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 74 amino acids of the MSH6 protein. While this particular variant has not been reported in the literature, loss-of-function variants in MSH6 are known to be pathogenic (PMID: 24362816, 18269114). In addition, many downstream truncating variants have been reported as pathogenic (PMID: 25980754, 14520694, 21155762, Invitae database), including two Ashkenazi Jewish founder mutations, c.3959_3962delCAAG (p.Ala1320Glufs*6), and c.3984_3987dupGTCA (p.Leu1330Valfs*12). For these reasons, this variant has been classified as Pathogenic. Although no functional studies have been performed to test the effects of this particular variant on MSH6 protein function or stability, it is expected to delete the C-terminal portion of the conserved MutS domain (PMID: 17531815, 24100870). This domain is necessary for the heterodimerization of MSH6 and MSH2 (PMID: 15952900, 16464007). -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.3850_3857dupACGTTCCT pathogenic mutation, located in coding exon 9 of the MSH6 gene, results from a duplication of ACGTTCCT at nucleotide position 3850, causing a translational frameshift with a predicted alternate stop codon (p.Y1287Rfs*43). This alteration occurs at the 3' terminus of theMSH6 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 74 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at